SEARCH

SEARCH BY CITATION

References

  • 1
    Krugman S, Giles JP. Viral hepatitis type B (MS-2-strain): further observations on natural history and prevention. N Engl J Med 1973; 288: 755760.
  • 2
    Krugman S, Overby LR, Mushahwar LK, Ling C, Fronsner GG, Deinhardt F. Viral hepatitis, type B: studies on natural history and prevention re-examined. N Engl J Med 1979; 300: 101106.
  • 3
    Brechot C, Hadchouel M, Scotto J, Fonck M, Potet M, Vyas GN, Tiollais P. State of B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver disease. Proc Natl Acad Sci U S A 1981; 78: 39063910.
  • 4
    Blum HE, Offensperger WB, Walter FW, Offensperger S, Gerok W. Latent hepatitis B virus infection with full-length viral genome in a patient serologically immune to hepatitis B virus infection. Liver 1988; 8: 307316.
  • 5
    Mason A, Yoffe B, Noonan C, Mearns M, Campbell C, Kelley A, Perrillo RB. Hepatitis B virus DNA in peripheral-blood mononu-clear cells in chronic hepatitis B after HBsAg clearance. Hepatology 1992; 16: 3641.
  • 6
    Kuhns M, McNamara A, Mason A, Campbell C, Perrillo RB. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 1992; 103: 16491656.
  • 7
    Blum HE, Liang TJ, Galun E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991; 14: 5663.
  • 8
    Kremsdorf D, Thiers T, Garreau F, Nakajima E, Chappey C, Schellekens H, Wands JR. et al. Nucleotide sequence analysis of hepatitis B virus genome isolated from serologically negative patients. In: HolingerFB, LemonSM, MargolisHS, eds. Hepatitis and Liver Disease: proceedings of the 1990 International Symposium on Viral Hepatitis. New York: Springer Verlag, 1990; 222226.
  • 9
    Kremsdorf D, Garreau F, Duclos H, Thiers V, Schellekens H, Petit MA, Brechot C. Complete nucleotide sequence and viral envelope protein expression of a hepatitis B virus DNA derived from a hepatitis B surface antigen-seronegative patient. J Hepatol 1993; 18: 244250.
  • 10
    Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H. et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994; 68: 26712676.
  • 11
    Adachi H, Kaneko S, Matsushita E, Inagaki Y, Unoura M, Kobayashi K. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology 1992; 16: 13341337.
  • 12
    Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K. The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res 1983; 11: 17471757.
  • 13
    Kaneko S, Miller RH, Feinstone SM, Unoura M, Kobayashi K, Hattori N, Purcell RH. Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci U S A 1989; 86: 312316.
  • 14
    Zhang Y-Y, Hansson BG, Kuo LS, Widell A, Nordnfelt E. Hepatitis B virus in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 1993; 17: 538544.
  • 15
    Milich DR, McNamara MK, McLachlan A, Thornton GB, Chisari FV. Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypep-tide allows circumvention of nonresponsiveness to the S region. Proc Natl Acad Sci U S A 1985; 82: 81688172.
  • 16
    Milich DR, Thornton GB, Neurath AR, Kent SB, Michel M-L, Tiollais P, Chisari FV. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 1985; 228: 11951199.
  • 17
    Milich DR, Jones JE, McLachlan A, Bitter G, Moriarty A, Hughes JL. Importance of subtype in the immune response to the preS(2) region of the hepatitis B surface antigen. II. Synthetic preS(2) immunogen. J Immunol 1990; 144: 35443551.
  • 18
    Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, Hwang LH. et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J Clin Invest 1992; 89: 8796.
  • 19
    Maruyama T, Lino S, Koike K, Yasuda K, Milich DR. Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology 1993; 105: 11411151.
  • 20
    Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489495.
  • 21
    Ou J-H, Rutter WJ. Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein. J Virol 1987; 61: 782786.
  • 22
    Neurath AR, Kent SBH, Strick N, Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 1984; 46: 429436.
  • 23
    Klingmuller U, Schaller H. Hepadnavirus infection requires interaction between the viral preS domain and a specific hepatocellular receptor. J Virol 1993; 67: 74147422.
  • 24
    Petit MA, Dubanchet S, Capel F, Voet P, Dauquet C, Hauser P. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-PreS-1:21-24. Virology 1991; 180: 483491.
  • 25
    Petit MA, Strick N, Dubanchet S, Capel F, Neurath AR. Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cell) and preS1-specific ligands. Mol Immunol 1991; 28: 517521.
  • 26
    Machida A, Kishimoto S, Ohnuma H, Miyamoto H, Baba K, Oda K, Nakamura T. et al. A hepatitis B surface antigen polypeptide (p31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 1983; 28: 268274.
  • 27
    Machida A, Kishimoto S, Ohnuma H, Baba K, Ito Y, Miyamoto H, Funatsu G. et al. A polypeptide containing 55 amino acid residues coded by PreS region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 1984; 86: 910918.
  • 28
    Krone B, Lenz A, Heermann K-H, Seifer M, Xuangyong L, Gerlich WH. Interaction between hepatitis B surface protein and monomeric human serum albumin. Hepatology 1990; 11: 10501078.
  • 29
    Wands JR, Carlson RI, Schoemaker H, Isselbacher KJ, Zurawski VR. Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies. Proc Natl Acad Sci U S A 1981; 78: 12141218.
  • 30
    Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ. et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325329.
  • 31
    Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol 1991; 13(suppl 4): S105S107.
  • 32
    Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F. et al. Mutations within the S gene of hepatitis B virus transmitted from mother to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 1992; 32: 264268.
  • 33
    Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M. et al. Glyl45 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992; 184: 11521157.
  • 34
    McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI. et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 1992; 15: 757766.
  • 35
    Blum HE, Galun E, Liang TJ, von Weizaecker F, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991; 65: 18361842.
  • 36
    Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht H-J, Vitiello A. et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993; 150: 46594671.
  • 37
    Evans CF, Borrow P, de la Torre JC, Oldstone MBA. Virus-induced immunosuppression: kinetic analysis of the selection of a mutation associated with viral persistence. J Virol 1994; 68: 73677373.
  • 38
    Guilhot S, Fowler P, Portillo G, Margolskee RF, Ferrari C, Bertoletti A, Chisari FV. Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines. J Virol 1992; 66: 26702678.